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b Protein Folding: An unfolding story b HIV Integration: Inil for integration? 
TE Creighton (1995). CIUI: Bid. 5,353-356. 
Most studies of protein folding have been hampered by the com- 
plexity and cooperativity of the process, as well as the complica- 
tions introduced by slow cis-tmns isomerization of proline 
residues, Despite this, work on the proteins barnase and chymo- 
trypsin inhibitor 2 by Alan Fersht and his colleagues has made sig- 
nificant progress in the elucidation of a mechanism of folding that 
may well be general to most small globular proteins. As reviewed 
here, these studies show that the cooperativity of multiple interac- 
tions responsible for the stability of the native state is generated 
throughout the folded structure in the transition state for folding. 
Within the unfolded state, individual interactions are rapidly 
formed and rapidly disrupted. Rare species that have multiple 
interactions will be stabilized only if these interactions can form 
cooperative structures; accretion of structures that stabilize each 
other eventually leads to a state in which completion of folding is 
energetically favored, and can occur rapidly. 
1 April 1995, Dispatch, Current Biology 
Michael D Miller and Frederic D Bushman (1995). Cuvr. Bid. 
5,368-370. 
b Chromosome Structure: Coiling up chromosomes 
The HIV-l integrase has just been found to+ bind the newly- 
discovered cellular protein, integrase-interacting protein 1 (Inil). 
Binding to Inil appears to enhance integration efficiency, and is 
probably involved in the mechanism of integrase action, perhaps 
forming a ‘bridge’ between the integration machinery and host 
DNA. Inil has a high degree of homology to the yeast transcrip- 
tional activator Snfi, part of the Swi/Snf complex that was 
recently reported to alter the structure of nucleosomal DNA in 
vitro. It is therefore also possible that some similar activity of Inil, 
resulting in changes in nucleosomal structure and DNA topology, 
is involved in promoting integration.These findings, together with 
recent advances towards directing HIV-l integration to specific 
DNA sequences using the DNA-binding domain of the bacterio- 
phage X repressor, may have consequences for gene therapy It may 
now be possible to influence integration-site selection during 
retroviral infection for the safer delivery of DNA sequences, or for 
the insertional inactivation of a harmful gene. 
1 April 1995, Dispatch, Ctrneent Biology 
Susan M Gasser (1995). Curv. Bid. 5,357-360. 
The mechanism by which eukaryotic chromosomes condense as 
cells enter mitosis has long been inaccessible to molecular biologists. 
As reviewed here, an important clue has now been provided by the 
identification of a ubiquitous non&stone protein family, the SMCs. 
When the genes encoding these proteins are mutated in yeast, chro- 
mosomes do not condense.The SMC family members have strong 
structural similarity; they consist of an amino-terminal nucleotide- 
binding globular head domain, followed by two extended o-helical 
stretches that are likely to form a coiled-coil structure in the (puta- 
tive) dimer. The carboxy-terminal domain shows homology to the 
‘Walker B’ motif, which correlates with NTP hydrolysisThis struc- 
ture is reminiscent of mechanochemical motor proteins, suggesting 
that these proteins may ‘reel in’ or coil up DNA before mitosis. 
1 April 1995, Dispatch, Cuvvent Biology 
b Ion-Channel Gating: Twist to open 
Mark SP Sansom (1995). Curv. Bid. 5,373-375. 
b SH3 Domains: Minding your p’s and q’s 
Bruce J Mayer and Michael J Eck (1995). Curr. Bid. 5, 
364-367. 
SH3 domains are protein-protein interaction domains that are 
found in a wide variety of proteins ranging from cytoskeletal com- 
ponents to signal transduction enzymes, and which are thought to 
bind to short proline-rich peptides in their target proteins. The 
three-dimensional structures of no less than ten different SW3 
domains have been solved by X-ray crystallography or NMR spec- 
troscopy, with and without a variety of specific ligands.This wealth 
of structural data provides a solid foundation for building general 
models of SH3 domain-ligand interactions. Beyond binding speci- 
ficity, the most pressing questions about SH3 domains concern the 
consequences of binding and how binding is regulated. Binding of 
SH3 domains to the target protein frequently changes the activity of 
the target protein. SH3 domains may also regulate the activity of the 
protein they are part of, and intramolecular interactions may be 
important in regulating the activity of the SH3 domains themselves. 
1 April 1995, Dispatch, Cuvrent Biology 
The nicotinic acetylcholine receptor (nAChR), responsible for 
synaptic transmission at vertebrate neuromuscular junctions, is one 
of the best characterized ion channel proteins.The 9 A structure 
of the closed conformation of the nAChR, determined two years 
ago, has recently been complemented by a structure for the open 
conformation of the channel obtained using cryo-electron 
microscopy. The comparison of these two structures provides us 
with our first real picture of a channel gating mechanism, and 
reveals that acetylcholine binding leads to channel opening via a 
series of subunit rotations propagated from the extracellular 
acetylcholine binding sites to the membrane-spanning zone.This 
structural-gating model permits a more detailed molecular inter- 
pretation of mutational data. In particular, the key role of a trans- 
membrane kink region, which is shown to act as a ‘molecular 
swivel’ in the closed-to-open transition, has refocused attention on 
the leucine residue which sits at the apex of the kink and partially 
occludes the channel pore in the closed conformation. 
1 April 1995, Dispatch, Ctrrvent Biology 
b A conserved amino-terminal She domain binds to 
phosphotyrosine motifs in activated receptors and 
phosphopeptides 
Peter van der Geer, Sandra Wiley,Venus Ka-Man Lai, Jean Paul 
Olivier, Gerald D Gish, Robert Stephens, David Kaplan, Steven 
Shoelson andTony Pawson (1995). Ctlrv. Bid. 5,404-412. 
Signal transduction by growth factor receptor protein-tyrosine 
kinases is generally initiated by autophosphorylation on tyrosine 
residues following ligand binding. Phosphotyrosines within acti- 
vated receptors form binding sites for the Src homology 2 (SH2) 
domains of cytoplasmic signaling proteins. One such protein, She, 
is tyrosine-phosphorylated in response to a large number of 
growth factors and cytokines, becoming a target for the Grb2 
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adaptor protein, thus coupling normal and oncogenic protein- 
tyrosine kinases to Ras activation, She contains an SH2 domain at 
its carboxyl terminus, but the function of the amino-terminal half 
of the protein is unknown. The authors report that the She 
amino-terminal region binds to a number of tyrosine-phosphory- 
lated proteins in v-src-transformed cells. The domain also binds 
directly to the activated epidermal growth factor (EGF) receptor 
and to the autophosphorylated nerve growth factor receptor 
(Trk). Binding appears to be specific for phosphorylated tyrosine 
residues within the sequence NPXpY, which is conserved in many 
She-binding sites. The She amino-terminal region has little 
sequence similarity to known SH2 domains, suggesting that it rep- 
resents a new class of phosphotyrosine-binding modules. She may 
thus bind to tyrosine-phosphorylated proteins at both of its ends, 
acting as an ‘adaptor’ to link the proteins together. 
1 April 1995, Research Paper, Current Biology 
b Regulation of pre-mRNA processing by ~1% 
Henry Neel, Pierre Gondran, Dominique Weil and Francois 
Dautry (1995). Curr. Bio2. 5,413-422. 
Little is known of the contribution of pre-mRNA nuclear pro- 
cessing to the regulation of gene expression. The authors report 
that, in co-transfection experiments, an activated SYC gene can 
modify the splicing rates of TNFB and B globin transcripts, 
whereas an activated ras gene cannot. The src gene appears to have 
at least two distinct effects on pre-mRNA processing; it both 
slows down splicing and allows the export of partially spliced tran- 
scripts. This implies that multiple levels of regulation exist. These 
observations establish that specific signal transduction pathways 
have the capacity to regulate gene expression at a post-transcrip- 
tional level within the nucleus. This regulation could reflect a 
modulation by Src of the activity of components of the splicing 
and transport machineries, but could also involve RNA-binding 
proteins, which have been shown to interact with Src. 
1 April 1995, Research Paper, Current Biology 
b Elevated levels of wild-type p53 induced by radiolabeling 
of cells leads to apoptosis or sustained growth arrest 
JoYeargin and Martin Haas (1995). Curu. E&2.5,423-431. 
The tumor suppressor protein p53 regulates progression through the 
checkpoint between Gl and S phases of the cell cycle in response to 
radiation- or drug-induced DNA damage. The authors report that 
wild-type p53 protein concentrations rapidly increased to high 
levels after metabolic radiolabeling of cells with [3jS]methionine or 
[‘Hlthymidine. The increase was dependent on dose and time, and 
resulted in apoptosis of normal human peripheral blood lympho- 
cytes and of murine T-cell acute lymphoblastic leukemia cells. 
Radiolabeling of human diploid fibroblasts resulted in prolonged 
growth arrest. These changes did not occur in radiolabeled cells 
containing no p53 or only mutant $3 allelesThe results of experi- 
ments employing these radiolabeling techniques may be seriously 
influenced by the induction of aberrant cell-cycle arrest and/or 
apoptosis mediated by wild-type p53.The results suggest that ~53’s 
function as a checkpoint to allow DNA to be repaired may be 
secondary to its function in causing arrest or death of damaged cells. 
1 April 1995, Research Paper, Current Biology 
k Regulation of Caenorhabditis elegans degenerin proteins 
by a putative extracellular domain 
Jaime Garcia-Aiioveros, Charles Ma and Martin Chaltie (1995). 
Curr. Biol. 5,441-448. 
Dominant, gain-of-function mutants of members of the degenerin 
gene family of Caenorhabditis &guns (deg- 1, met-4 and met- IO) cause 
neurons to become vacuolated, swell, and die. The degenerins are 
homologous to ion channels; met-4 and met-10 are needed for the 
reception of gentle touch stimuli, and may therefore contribute to a 
mechanosensory ion channel. All of the dominant degeneration- 
causing mutations in degenerin genes affect equivalent residues in a 
hydrophobic region structurally similar to the H5 domain of several 
ion channels, which could form the channel lining. The authors 
show that a missense change in a predicted extracellular region of 
the proteins encoded by deg- 1 and nzec-4 degenerin mutants causes 
cell death. Mutations in either the predicted pore-lining or the pre- 
dicted extracellular regions of deg-1 are suppressed by additional, 
dominantly acting mutations that substitute larger for smaller 
residues in the channel lining which may block the pore of a multi- 
subunit channel.These findings suggest that the putative extracellu- 
lar domain negatively regulates degenerin activih/, perhaps by gating 
the channel. This region is not found in the homologous mam- 
malian genes, and may be required for more rapid regulation of the 
nematode channels to allow mechanosensation. 
1 April 1995, Research Paper, Current Biology 
k The cell cycle and sucl: from structure to function? 
JA Endicott and P Nurse (1995). Structure 3,321-325. 
The product of-the yeast Schizosaccharomyces pombe CKS/sucl gene, 
Pl3 suc*, is essential for the function of the cell cycle regulatory 
protein kinase p34cdc2 wz viva. But nearly a decade after their original 
characterization, ~13~~‘~ and its relatives, the CKS proteins (for 
CDC28 kinase subunit) still have no known catalytic activity This 
minireview focuses on the recently determined structures of p13sUc1, 
and its human equivalent, p9CKS2.The structures provide some long- 
awaited clues about the role of CKS/sucl in cell cycle control. Both 
structures reveal a potential phosphotyrosine-binding site and a 
second ‘hydrophobic and aromatic patch’ site. An association of 
pl3SUC’ with tyrosine-phosphorylated ~34~~~~ may block access of 
the p80cdc25- encoded tyrosine phosphatase, thus preventing dephos- 
phorylation and activation of the protein kinase. An additional 
binding interaction known to occur with active ~34~~~~ kinase 
may be mediated by the hydrophobic and aromatic patch. 
15 April 1995, Minireview, Structure 
t Problems in simulating macromolecular movements 
Donald LD Caspar (1995). Structure 3,327-329. 
Although it may be appealing to think of protein molecules as little 
pieces of biological machinery that function in a mechanistically 
predictable wa)s Caspar suggests that recent structural studies show 
that protein molecules may behave more like organisms, carrying 
out their specitic functions with some stochastic individuality. At 
issue are the idiosyncratic behavior of a protein and the problems 
encountered in tracking its movements. How are the atomic move- 
ments in protein molecules correlated with each other and how 
well does a molecular dynamics simulation sample these correla- 
tions? Protein molecules have sharply defined average structures 
only in well ordered lattices. But even in a crystal, the accuracy 
with which the average structure can be determined appears less 
certain than generally assumed by protein cyrstallographers.Thus, 
insufficient sampling of conformational sub-states by current mol- 
ecular dynamics simulations, due to the constraints imposed by 
computational resources, produces deficient representations of the 
fluctuating separations between pairs of atoms in macromolecules. 
15 April 1995, Minireview, Structure 
b The structural basis for seryl-adenylate and Ap,A 
synthesis by seryl-tRNA synthetase 
Hassan Belrhali, Anya Yaremchuk, Michael Tukalo, Carmen 
Berthet-Colominas, Bjarne Rasmussen, Peter Bosecke, Olivier 
Diat and Stephen Cusack (1995). Structure 3,341-352. 
Sery-tRNA synthetase (SerRS) is a homodimeric class II amino- 
acyl-tRNA synthetase that specifically charges cognate tRNAs 
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with serine. In the first step of this two-step reaction, MgATP 
and serine react to form the activated intermediate, seryl-adenyl- 
ate. The serine is subsequently transferred to the tRNA. In 
common with most other synthetases, SerRS can also synthesize 
the dinucleotide diadenosine tetraphosphate (Ap4A) by attack of a 
second ATP molecule on the enzyme-bound adenylate.Ap4A has 
been implicated in a number of metabolic processes and stress- 
related phenomena. The authors describe three new crystallo- 
graphic structures of SerRS at 2.3-2.6 A resolution complexed 
with ATP, seryl-adenylate and Ap,A, each in the presence of 
Mn2+. Superposition of these structures allows the authors to 
propose a common reaction mechanism in which both Ap,A and 
seryl-adenylate are formed by in-line displacement reactions 
involving a pentavalent transition state at the a-phosphate position 
of the adenylate, but with the displacement going in opposite 
directions. The divalent cation is essential for both reactions and 
may be directly involved in stabilizing the transition state. 
15 April 1995, Research Article, Structure 
b Structure of HIV-l reverse transcriptase in a complex 
with the non-nucleoside inhibitor wAPA R 95845 at 
2.8 A resolution 
J Ding, K Das, C Tantillo, W Zhang, AD Clark, Jr, S Jessen, X 
Lu, Y Hsiou, A Jacobo-Molina, K Andries, R Pauwels, H 
Moereels, L Koymans, PAJ Janssen, RH Smith, Jr, M Kroeger 
Koepke, CJ Michejda, SH Hughes and E Arnold (1995). 
Stvuctuve 3,365-379. 
HIV-l reverse transcriptase (RT) is a multifunctional enzyme that 
copies the RNA genome of HIV-l into DNA. It is a crucial 
target for structure-based drug design, and potent inhibitors have 
been identified, whose efficacy, however, is limited by drug resis- 
tance.The authors report the 2.8 A resolution crystal structure of 
HIV-l RT in complex with a non-nucleoside inhibitor, 01- 
anilinophenylacetamide (a-APA) R95845.The inhibitor binds in 
a hydrophobic pocket lined by a number of aromatic side chains 
that are likely to stabilize the binding of a non-nucleoside 
inhibitor, explaining the observation that non-nucleoside 
inhibitors invariably contain at least one aromatic ring.The muta- 
tions that cause high-level resistance to non-nucleoside inhibitors 
are located close to the bound inhibitor, and presumably affect the 
stability of inhibitor binding. Comparison of the structure with 
that of HIV-l RT bound to a double-stranded DNA template- 
primer and the Fab of a monoclonal antibody shows significant 
changes in the local environment of the inhibitor-binding pocket 
which may explain how ol-APA inhibits HIV-l RT. 
15 April 1995, Research Article, Structure 
b Comparative analysis of the X-ray structures of HIV-l 
and HIV-2 proteases in complex with CGP 53820, a 
novel pseudosymmetric inhibitor 
JP Priestle, A Fassler, J Rosel, M Tintelnot-Blomley, P Strop 
and MG Griitter (1995). Structure 3,381-389. 
The less pathogenic subtype of the human immunodeficiency 
virus (HIV), HIV-2, has recently been shown to be responsible for 
the accelerated spread ofAIDS in India and East Asia.The protease 
enzymes from HIV-l and HIV-2 are aspartic acid proteases which 
share about 50 % sequence identity and are essential for matura- 
tion of the infectious particle. The authors report the X-ray crystal 
strucmres of both proteases, each in complex with the pseudosym- 0 
metric inhibitor, CGP 53820, to 2.2 A and 2.3 A resolution, 
respectively. They find that minor sequence changes in subsites at 
the active site can explain some of the observed differences in sub- 
strate and inhibitor binding between the two enzymes. As some of 
the point mutations that confer drug resistance on HIV-l protease 
change the HIV-l sequence to that of HIV-2 protease, this struc- 
tural analysis may help in the design of inhibitors that do not 
easily trigger the development of drug-resistant mutants. 
15 April 1995, Research Article, Structure 
